MSI1 and endometrial cancer: It is in agreement with (and extends beyond) the limited number of previous studies evaluating the role of Musashi-1 in endometrial cancer: Previous work showed that Musashi-1 is overexpressed in endometrial cancer [16] and high expression is prognostically unfavorable [18].